Establishment and Characterization of EGFR and Mig6 Cell Lines
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization : Samsung Medical Center
Other organizations : Boston University, National Cancer Center, Broad Institute
Variable analysis
- Stable expression of EGFR and/or Mig6 in NIH-3T3 cell lines (established by retroviral infections and pooled)
- Unspecified
- NIH-3T3 cells (without EGFR and/or Mig6 expression)
- HEK-293T cells
- PC9 cells
- HCC827 cells
- A549 cells
- DMEM supplemented with 10% bovine serum (for NIH-3T3 and HEK-293T cells)
- RPMI supplemented with 10% fetal bovine serum (for PC9, HCC827, and A549 cells)
- EGF stimulation at 25 ng/ml for 5 minutes
- Positive control: Unspecified
- Negative control: Unspecified
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!